• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women suffering from ADHD have to make a difficult choice on whether to keep or stop taking ADHD medication during pregnancy and breast-feeding. There are few data regarding how to get adhd medication without diagnosis exposure over time may affect the fetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication during the uterus don't develop neurological disorders like hearing loss or impaired vision seizures, febrile seizures or IQ impairment. The authors acknowledge the need for higher-quality research.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medication need to evaluate the benefits of using it against the potential risks for the foetus. Doctors don't have the necessary data to give clear guidelines, but they can provide information about risks and benefits that assist pregnant women in making informed choices.

A study published in Molecular Psychiatry concluded that women who took ADHD medication during their early pregnancy were not at higher risk of fetal malformations, or structural birth defects. The researchers used a large, population-based case-control study to determine the prevalence of major structural birth defects in infants born to mothers who had taken stimulants during the early stages of pregnancy and those who had not. Pediatric cardiologists, clinical geneticists and other experts looked over the cases to ensure that the classification was correct and to eliminate any bias.

The study conducted by the researchers was not without limitations. The researchers were not able in the beginning, to separate the effects triggered by the medication from the disorder. This limitation makes it difficult for researchers to determine if the few associations observed between the groups exposed were due to the use of medication or affected by comorbidities. Additionally the researchers did not examine the long-term outcomes of offspring.

The study did find that infants whose mothers had taken ADHD medication during pregnancy were at slightly higher risk of being admitted to the neonatal intensive care unit (NICU) than those whose mothers had not taken any medication or cut back on their medications prior to or during pregnancy. This was due to central nervous system-related disorders and the higher risk of admission was not found to be affected by the type of stimulant medication was used during pregnancy.

Women who were taking stimulant ADHD medication during pregnancy also had an increased risk of having a caesarean delivery or having a baby born with a low Apgar score (less than 7). These risks did not appear to be influenced by the kind of medication used during pregnancy.

The researchers suggest that the risk of a small amount with the use of ADHD medications during the early stages of pregnancy could be offset by the greater benefit to both the mother and child from continued treatment for the woman's disorder. Physicians should talk to their patients about this issue and try to help them improve coping skills which can lessen the effects of her disorder on her daily life and relationships.

Interactions with Medication

As more women than ever before are being diagnosed with ADHD and treated with medication, the dilemma of whether or not to end treatment during pregnancy is one that doctors are having to confront. Often, these decisions are taken in the absence of clear and authoritative evidence in either case, which means that doctors must weigh what they know, the experiences of other doctors, and what research suggests on the subject, along with their best judgment for each individual patient.

Particularly, the subject of possible risks to the baby can be a challenge. The research that has been conducted on this topic is based on observations rather than controlled studies and many of the findings are in conflict. Furthermore, most studies restrict their analysis to live births, which may underestimate severe teratogenic effects that result in abortion or termination of the pregnancy. The study discussed in this journal club addresses these limitations by examining data on both live and deceased births.

Conclusion: While some studies have shown an association between ADHD medications and certain birth defects, other studies have not shown such a relationship. Most studies have shown a neutral, or even slightly negative, effect. Therefore, a careful risk/benefit assessment is required in every situation.

It can be difficult, if not impossible, for women with ADHD to stop taking their medication. In a recent piece published in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping adhd and depression medication - Yogicentral officially announced, medications during pregnancy can increase depression and feelings of loneliness. In addition, a decrease in medication can affect the ability to do job-related tasks and drive safely that are crucial aspects of a normal life for many people with ADHD.

She suggests that women who are unsure whether to take the medication or stop due to pregnancy should educate family members, colleagues, and friends about the condition, the effects on daily functioning, and the benefits of continuing the current treatment. It can also help a woman feel confident about her decision. Certain medications can be passed through the placenta. If the patient decides to not take her ADHD medication while breastfeeding, it is important to be aware that the drug could be transferred to the baby.

Risk of Birth Defects

As the use and abuse of adhd medication prices uk drugs to treat symptoms of attention deficit disorder hyperactivity disorder (ADHD), increases as does the concern about the possible effects of the drugs on foetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge on this topic. Researchers used two massive datasets to analyze over 4.3 million pregnancies and determine if stimulant medication use increased the risk of birth defects. Although the risk overall is low, the researchers found that exposure in the first trimester to ADHD medicines was associated with an increase in the risk of certain heart defects such as ventriculo-septal defect (VSD).

The authors of the study found no association between early use of medication and other congenital abnormalities, like facial clefting, or club foot. The findings are in line with previous studies showing a small but significant increase in the risk of heart malformations among women who can prescribe adhd medication for adults started taking ADHD medications prior to the time of the birth of their child. The risk increased in the latter stages of pregnancy when many women decided to stop taking their medication.

Women who took ADHD medication in the first trimester of pregnancy were also more likely to experience caesarean sections, a low Apgar score after delivery and a baby who needed help breathing at birth. The authors of the study were unable to eliminate bias due to selection because they limited the study to women without other medical conditions that could have contributed to the findings.

Researchers hope that their research will provide doctors with information when they see pregnant women. They advise that while a discussion of the risks and benefits is crucial, the decision to stop or continue treatment should be based on each woman's needs and the severity of her ADHD symptoms.

The authors caution that, even though stopping the medication is a possibility to look into, it is not recommended due to the high rate depression and other mental disorders among women who are pregnant or have recently given birth. Additionally, research suggests that women who stop taking their medication will have a difficult transitioning to life without them after the baby is born.

Nursing

It can be a stressful experience becoming a mother. Women who suffer from ADHD who must work through their symptoms while attending doctor appointments as well as getting ready for the arrival of a baby and getting used to new routines at home may face a lot of challenges. Many women decide to continue taking their private adhd assessment medway medication during pregnancy.

The majority of stimulant medicines pass through breast milk in low amounts, so the risk to the nursing infant is very low. However, the frequency of medication exposure to the infant can differ based on dosage, frequency it is taken and at what time it is administered. In addition, different drugs enter the infant's system through the gastrointestinal tract, or through breast milk. The impact of these medications on the health of a newborn isn't fully known.

Because of the lack of evidence, some doctors may recommend stopping stimulant medication during a woman's pregnancy. This is a difficult choice for the patient, who must balance the benefits of continuing her medication against the potential risks to the embryo. As long as more information is available, doctors can inquire about pregnant patients if they have an background of ADHD or if they intend to take medication in the perinatal stage.

Numerous studies have demonstrated that women can continue to take their ADHD medication safely during pregnancy and while breast-feeding. As a result, more and more patients choose to do so, and in consultation with their doctor they have found that the benefits of maintaining their current medication outweigh any potential risks.

It's important for women with inattentive adhd medication adults who are contemplating breastfeeding to seek a specialist psychiatrist's guidance prior to becoming pregnant. They should discuss their medication with their doctor as well as the pros and cons of continuing treatment. This includes non-pharmacological methods. Psychoeducation should also be provided to help pregnant people with ADHD be aware of their symptoms and the underlying disorder, learn about available treatment options and reinforce existing strategies for managing. This should be a multidisciplinary approach, which includes the GP as well as obstetricians, psychiatry and obstetricians. Pregnancy counseling should include discussion of a treatment plan for the mother and the child, as well as monitoring for indicators of deterioration, and, if needed adjustments to the medication regimen.